Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 65 | 58 | 58 | 58 | 54 |
| Accounts receivable | 15 | 103 | 72 | -28 | -48 |
| Other Working Capital | -181 | 1,381 | -3,284 | 1,938 | 943 |
| Other Operating Activity | -3,314 | -6,897 | -6,793 | -10,889 | -5,847 |
| Operating Cash Flow | $-3,415 | $-5,354 | $-9,947 | $-8,921 | $-4,898 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -4 | -44 | -48 | -9 |
| Investing Cash Flow | $-6 | $-4 | $-44 | $-48 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -14 | -14 | -14 | -14 |
| Financing Cash Flow | $-14 | $-14 | $-14 | $-14 | $-14 |
| Exchange Rate Effect | -968 | 847 | 3 | N/A | N/A |
| Beginning Cash Position | 44,942 | 49,468 | 59,470 | 65,532 | 70,454 |
| End Cash Position | 40,540 | 44,942 | 49,468 | 59,470 | 65,532 |
| Net Cash Flow | $-3,434 | $-5,372 | $-10,005 | $-8,982 | $-4,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,415 | -5,354 | -9,947 | -8,921 | -4,898 |
| Capital Expenditure | -6 | -4 | -44 | -48 | -9 |
| Free Cash Flow | -3,420 | -5,358 | -9,991 | -8,969 | -4,908 |